QSS
SGMO

Quantitative Systematic Strategies’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Quantitative Systematic Strategies’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-11,742
Closed -$126K – 575
2019
Q2 		$126K Buy
+11,742
New +$125K 0.02% 434
2019
Q1 		– Sell
-20,364
Closed -$234K – 605
2018
Q4 		$234K Buy
+20,364
New +$253K 0.05% 484
2018
Q3 		– Sell
-10,881
Closed -$155K – 773
2018
Q2 		$155K Buy
+10,881
New +$181K 0.03% 576
2016
Q3 		– Sell
-28,176
Closed -$163K – 477
2016
Q2 		$163K Buy
+28,176
New +$180K 0.08% 368

Other funds holding SGMO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Quantitative Systematic Strategies's SGMO Position: Q3 2019 in Review

Quantitative Systematic Strategies sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2019, closing a stake of 11,742 shares — an estimated $126K sold.

Quantitative Systematic Strategies first reported a position in SGMO in Q2 2016 and held it in 4 quarters. The position peaked at $234K in Q4 2018. 184 funds tracked by Wall St. Rank hold SGMO as of Q3 2019.

  • Quantitative Systematic Strategies reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2019 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 11,742 SANGAMO THERAPEUTICS INC shares in Q3 2019, an estimated $126K.
  • Quantitative Systematic Strategies first reported a position in SANGAMO THERAPEUTICS INC in Q2 2016 and held it in 4 quarters.
  • Quantitative Systematic Strategies's SANGAMO THERAPEUTICS INC position peaked at $234K in Q4 2018.
  • 184 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2019.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2019, filed 7 Nov 2019.